Bovine herpesvirus type 1 (BHV-1) is an important cofactor in the bovine respiratory disease complex

Veterinary Clinics of North America - Food Animal Practice

Volumn 26, Issue 2, 2010, Pages 303-321

  Jones, Clinton ^a   Chowdhury, Shafiqul ^b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Bovine herpesvirus 1; Bovine respiratory disease complex (BRDC); Immune suppression; Latency; Shipping fever; Vaccines

Indexed keywords

BOS; BOVINAE; BOVINE HERPESVIRUS 1; HERPESVIRIDAE; HUMAN HERPESVIRUS 1;

HERPES VACCINE; VIRUS PROTEIN;

ANIMAL; ANIMAL DISEASE; BOVINE HERPES VIRUS; CATTLE; CATTLE DISEASE; FEMALE; HERPES VIRUS INFECTION; IMMUNOLOGY; MALE; METABOLISM; REVIEW; VIROLOGY;

ANIMALS; BOVINE RESPIRATORY DISEASE COMPLEX; CATTLE; CATTLE DISEASES; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; HERPESVIRUS VACCINES; MALE; VIRAL PROTEINS;

EID: 77954171901     PISSN: 07490720     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvfa.2010.04.007     Document Type: Review

References (141)

1. Turin L., Russo S., Poli G. BHV-1: new molecular approaches to control a common and widespread infection. Mol Med 1999, 5:261-284.
2. Metzler A.E., Matile H., Gasman U., et al. European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides and reactivity with monoclonal antibodies. Arch Virol 1985, 85:57-69.
3. van Oirschot J.T. Bovine herpesvirus in semen of bulls and the risk of transmission: a brief overview. Vet Q 1995, 17:29-33.
4. D'Arce R.C.F., Almedia R.S., Silva T.C., et al. Restriction endonucleases and monoclonal antibody analysis of Brazilian isolates of bovine herpesvirus 1 and 5. Vet Microbiol 2002, 88:315-334.
5. Edwards S., White H., Nixon P. A study of the predominant genotypes of bovine herpesvirus 1 isolated in the U.K. Vet Microbiol 1990, 22:213-223.
6. Yates W.D. A review of infectious bovine rhinotracheitis, shipping fever pneumonia, and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med 1982, 46:225-263.
7. Ackermann M., Engels M. Pro and contra IBR-eradication. Vet Microbiol 2005, 113:293-302.
8. Sausker E.A., Dyer N.W. Seroprevalence of OHV-2, BVDV, BHV-1, and BRSV in ranch-raised bison (Bison bison). J Vet Diagn Invest 2002, 14:68-70.
9. Lata J., Kanani A.N., Patel T.J., et al. Seroprevalence of bovine herpesvirus 1 (BHV-1) in Indian breeding bulls of Gujarat. Buffalo Bull 2008, 27:165-169.
10. Malmurugan S., Raja A., Saravanabava K., et al. Seroprevalence and infectious bovine rhinotracheitis in cattle and buffaloes using Avidin-Biotin ELISA. Cheiron 2004, 33:146-149.
11. NASS Agricultural statistics board 1996, US Department of Agriculture, Washington, DC.
12. Bowland S.L., Shewen P.E. Bovine respiratory disease: commercial vaccines currently available in Canada. Can Vet J 2000, 41(1):33-48.
13. Tikoo S.K., Campos M., Babiuk L.A. Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv Virus Res 1995, 45:191-223.
14. Carter J.J., Weinberg A.D., Pollard A., et al. Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1. J Virol 1989, 63(4):1525-1530.
15. Griebel P., Ohmann H.B., Lawmann M.J., et al. The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. J Gen Virol 1990, 71(Pt 2):369-377.
16. Griebel P., Qualtiere L., Davis W.C., et al. T lymphocyte population dynamics and function following a primary bovine herpesvirus type-1 infection. Viral Immunol 1987, 1(4):287-304.
17. Griebel P.J., Qualtiere L., Davis W.C., et al. Bovine peripheral blood leukocyte subpopulation dynamics following a primary bovine herpesvirus-1 infection. Viral Immunol 1987, 1(4):267-286.
18. Nataraj C., Eidmann S., Hariharan M.J., et al. Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules. Viral Immunol 1997, 10(1):21-34.
19. Hariharan M.J., Nataraj C., Srikumaran S. Down regulation of murine MHC class I expression by bovine herpesvirus 1. Viral Immunol 1993, 6(4):273-284.
20. Hinkley S., Hill A.B., Srikumaran S. Bovine herpesvirus-1 infection affects the peptide transport activity in bovine cells. Virus Res 1998, 53(1):91-96.
21. Winkler M.T., Doster A., Jones C. Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle. J Virol 1999, 73(10):8657-8668.
22. Abril C., Engels M., Limman A., et al. Both viral and host factors contribute to neurovirulence of bovine herpesvirus 1 and 5 in interferon receptor-deficient mice. J Virol 2004, 78(7):3644-3653.
23. Liang X., Tang M., Manns B., et al. Identification and deletion mutagenesis of the bovine herpesvirus 1 dUTPase gene and a gene homologous to herpes simplex virus UL49.5. Virology 1993, 195:42-50.
24. Liang X., Chow B., Raggo C., et al. Bovine herpesvirus 1 UL49.5 homolog gene encodes a novel viral envelope protein that forms a disulfide-linked complex with a second virion structural protein. J Virol 1996, 70:1448-1454.
25. Wu S.X., Zhu X.P., Letchworth G.J. Bovine herpesvirus 1 glycoprotein M forms a disulfide-linked heterodimer with the U(L)49.5 protein. J Virol 1998, 72:3029-3036.
26. Jöns A., Dijkstra J.M., Mettenleiter T.C. Glycoproteins M and N of pseudorabies virus form a disulfide-linked complex. J Virol 1998, 72:550-557.
27. Rudolph J., Seyboldt C., Granzow H., et al. The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M. J Virol 2002, 76:2952-2963.
28. Brack A.R., Dijkstra J.M., Granzow H., et al. Inhibition of virion maturation by simultaneous deletion of glycoproteins E, I, and M of pseudorabies virus. J Virol 1999, 73:5364-5372.
29. Koppers-Lalic D., Reits E.A., Ressing M.E., et al. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc Natl Acad Sci U S A 2005, 102:5144-5149.
30. Lipińska A.D., Koppers-Lalic D., Rychlowski M., et al. Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M. J Virol 2006, 81:5822-5832.
31. Androlewicz M.J., Anderson K.S., Cresswell P. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A 1993, 90:9130-9134.
32. Koch J., Gruntrum R., Heintke S., et al. Functional dissection of the transmembrane domains of the transporter associated with antigen processing (TAP). J Biol Chem 2004, 279:10142-10147.
33. van Endert P.M., Saveanu L., Hewitt E.W., et al. Powering the peptide pump: TAP crosstalk with energetic nucleotides. Trends Biochem Sci 2002, 27:454-461.
34. Ahn K., Meyer T.H., Uebel S., et al. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J 1996, 15:3247-3255.
35. Ambagala A.P., Gopinath R.S., Srikumaran S. Peptide transport activity of the transporter associated with antigen processing (TAP) is inhibited by an early protein of equine herpesvirus-1. J Gen Virol 2004, 66:2383-2394.
36. Hughes E.A., Hammond C., Cresswell P. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteosome. Proc Natl Acad Sci U S A 1997, 94:1896-1901.
37. Everett R.D. ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 2000, 22(8):761-770.
38. Fraefel C., Zeng J., Coffat Y., et al. Identification and zinc dependence of the bovine herpesvirus 1 transactivator protein BICP0. J Virol 1994, 68(5):3154-3162.
39. Zhang Y., Jones C. Identification of functional domains within the bICP0 protein encoded by BHV-1. J Gen Virol 2005, 86:879-886.
40. Inman M., Zhang Y., Geiser V., et al. The zinc ring finger in the bICP0 protein encoded by bovine herpes virus-1 mediates toxicity and activates productive infection. J Gen Virol 2001, 82:483-492.
41. Geiser V., Jones C. Stimulation of bovine herpesvirus 1 productive infection by the adenovirus E1A gene and a cell cycle regulatory gene, E2F-4. J Gen Virol 2003, 84:929-938.
42. Zhang Y., Jones C. The bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription. J Virol 2001, 75(20):9571-9578.
43. Zhang Y., Jiang Y., Zhou J., et al. The bovine herpes virus 1 (BHV-1) immediate early protein (bICP0) interacts with the histone acetyltransferase p300, and these interactions correlate with stimulation of gC promoter activity. J Gen Virol 2006, 87:1843-1851.
44. Henderson G., Zhang Y., Jones C. The bovine herpesvirus 1 gene encoding infected cell protein 0 (bICP0) can inhibit interferon-dependent transcription in the absence of other viral genes. J Gen Virol 2005, 86:2697-2702.
45. Saira K., Zhou Y., Jones C. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 (IRF3), and consequently inhibits beta interferon promoter activity. J Virol 2007, 81:3077-3086.
46. Dia L., Zhang B., Fan J., et al. Herpes virus proteins ICP0 and BICP0 can activate NF-kB by catalyzing IkBa ubiquitination. Cell Signal 2005, 17:217-229.
47. Yoneyama M., Suhara W., Fukuhara M., et al. Direct triggering of the type 1 interferon system by virus infection: activation of a transcription factors containing IRF-3 and CBP/p300. EMBO J 1998, 17:1087-1095.
48. Sato M., Taniguchi T., Tanaka N. The interferon system and interferon regulatory factor transcription factors-studies from gene knockout mice. Cytokine Growth Factor Rev 2001, 12:133-142.
49. Yuang Y., Lowther W., Kellum M., et al. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci U S A 1998, 95:9837-9842.
50. Honda K., Yanai H., Negishi H., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
51. Saira K., Jones C. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) associates with interferon regulatory factor 7 (IRF7), and consequently inhibits beta interferon promoter activity. J Virol 2009, 83:3977-3981.
52. Bryant N.A., Davis-Poynter N., Vanderplasschen A., et al. Glycoprotein G isoforms from some alphaherpesvirus function as broad-spectrum chemokine binding proteins. EMBO J 2003, 22:833-846.
53. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998, 392:565-568.
54. Kaashoek M.J., Fijsewijk F.A., Ruuls R.C., et al. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene. Vaccine 1998, 16:802-809.
55. Jeyaseelan S., Sreevatson S., Maheswaran S.K. Role of Mannheimia haemolytica leukotoxin in the pathogenesis of bovine pneumonic pasteurellosis. Anim Health Res Rev 2002, 3:69-82.
56. Rivera-Rivas J.J., Kisiela D., Czuprynski C.J. Bovine herpesvirus type 1 infection of bovine bronchial epithelial cells increases neutrophil adhesion and activation. Vet Immunol Immunopathol 2009, 131:167-176.
57. Rouse B.T., Babiuk L.A. Mechanism of recovery from herpesvirus infections. Can J Comp Med 1978, 42:414-427.
58. Straub O.C., Ahl R. Lokale interferonbildung beim rind nach intranasaler infektion mit avirulentm IBR-IPV-virus und deren wirkung auf eine anschliebende inkection mit maul und klauenseuche-virus. Zbl Vet Med B 1976, 23:470-482.
59. Babiuk L.A., Bielefeldt Ohamnn H., Gifford H., et al. Effect of bovine alpha 1 interferon on bovine herpesvirus type 1 induced respiratory disease. J Gen Virol 1985, 66:2383-2394.
60. Jensen J., Schulz R.D. Bovine natural cell mediated cytotoxicity (NCMC): activation by cytokines. Vet Immunol Immunopathol 1990, 24:113-129.
61. Lawman M.J.P., Gifford G., Gyongyossy-Issa M., et al. Activity of polymorphonuclear (PMN) leukocytes during bovine herpesvirus-1 induced respiratory disease: effect of recombinant bovine interferon alpha I1. Antiviral Res 1987, 8:225-237.
62. Cook C.B., Splitter G.A. Characterization of bovine mononuclear cell population with natural cytotoxic activity against bovine herpesvirus-1 infected cells. Cell Immunol 1989, 120:240-249.
63. Campos M., Rossi C.R. Cytotoxicity of bovine lymphocytes after treatment with lymphokines. Am J Vet Res 1986, 47:1524-1528.
64. Amadori M., Archetti L.L., Vernadi R., et al. Target recognition by bovine mononuclear, MHC-untreated cytotoxic cells. Vet Microbiol 1992, 33:383-392.
65. Marshall R.L., Israel B.A., Letchworth G.J. Monoclonal antibody analysis of bovine herpesvirus-1 glycoprotein antigenic areas relevant to natural infection. Virology 1988, 165:338-347.
66. Van Drunen Littel-van den Hurk S., Babiuk L.A. Polypeptide specificity of the antibody response after primary and recurrent infection with bovine herpesvirus 1. J Clin Microbiol 1986, 23:274-282.
67. Van Drunen Littel-van den Hurk S., Tikoo S.K., Liang X., et al. Bovine herpesvirus-1 vaccines. Immunol Cell Biol 1993, 71:405-420.
68. Rouse B.T., Wardley R.C., Babiuk L.A. Antibody dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erythrocytes and herpesvirus-infected bovine target cells. Infect Immun 1976, 13:1433-1441.
69. Rouse B.T., Grewal A.S., Babiuk L.A. Complement enhances antiviral antibody dependent cell toxicity. Nature 1977, 266:456-458.
70. Rouse B.T., Wardley R.C., Babiuk L.A. Enhancement of antibody dependent cell toxicity of herpesvirus infected cells by complement. Infect Immun 1977, 18:660-665.
71. Rouse B.T., Babiuk L.A. The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells. J Immunol 1977, 118:618-624.
72. Van Drunen Littel-van den Hurk S. Cell-mediated immune responses induced by BHV-1: rational vaccine design. Expert Rev Vaccines 2007, 6:369-380.
73. Deshpande M.S., Ambagala T.C., Hegde N.R., et al. Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization. Vaccine 2002, 20:3744-3751.
74. Huang Y., Babiuk L.A., van Drunen Littel-van den Hurk S. Immunization with a bovine heprsvirus-1 glycoprotein B DNA vaccine induces cytotoxic T lymphocyte responses in mice and cattle. J Gen Virol 2005, 88:887-898.
75. Denis M., Slaoui M., Keil G.M., et al. Identification of different target glycoproteins for bovine herpesvirus-1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Immunology 1993, 78:7-13.
76. Campos M., Bielefeldt O.H., Hutchings D., et al. Role of interferon gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells. Cell Immunol 1989, 120:259-269.
77. Hutchings D.L., van Drunen Littel-van den Hurk S., Babiuk L.A. Lymphocyte proliferative responses to separated bovine herpesvirus 1 proteins in immune cattle. J Virol 1990, 64:5114-5122.
78. Leary T.P., Splitter G.A. Recombinant herpesviral proteins produced by cell-free translation provide a novel approach for the mapping of T lymphocyte epitopes. J Immunol 1990, 145:718-723.
79. Tikoo S.K., Campos M., Popowych Y.I., et al. Lymphocyte proliferative responses to recombinant bovine herpesvirus virus type 1 (BHV-1) glycoprotein gD (gIV) in immune cattle: identification of a T cell epitope. Viral Immunol 1995, 8:19-25.
80. + T lymphocytes. Nature 2003, 421:852-856.
81. Shedlock D.J., Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003, 300:337-339.
82. Devireddy L.R., Jones C. Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release. J Virol 1999, 73(5):3778-3788.
83. Misra V., Walker S., Hayes S., et al. The bovine herpesvirus alpha gene trans-inducing factor activates transcription by mechanisms different from those of its herpes simplex virus type 1 counterpart VP16. J Virol 1995, 69(9):5209-5216.
84. Wirth U.V., Vogt B., Schwyzer M. The three major immediate-early transcripts of bovine herpesvirus 1 arise from two divergent and spliced transcription units. J Virol 1991, 65(1):195-205.
85. Wirth U.V., Fraefel C., Vogt B., et al. Immediate-early RNA 2.9 and early RNA 2.6 of bovine herpesvirus 1 are 3' coterminal and encode a putative zinc finger transactivator protein. J Virol 1992, 66(5):2763-2772.
86. Jones C. Alphaherpesvirus latency: its role in disease and survival of the virus in nature. Adv Virus Res 1998, 51:81-133.
87. Jones C. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev 2003, 16:79-95.
88. Schang L., Jones C. Analysis of bovine herpesvirus 1 transcripts during a primary infection of trigeminal ganglia of cattle. J Virol 1997, 71(9):6786-6795.
89. Inman M., Lovato L., Doster A., et al. A mutation in the latency related gene of bovine herpesvirus 1 interferes with the latency-reactivation cycle of latency in calves. J Virol 2002, 76:6771-6779.
90. Jones C., Geiser V., Henderson G., et al. Functional analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency. Vet Microbiol 2006, 113:199-210.
91. Devireddy L.R., Jones C. Alternative splicing of the latency-related transcript of bovine herpesvirus 1 yields RNAs containing unique open reading frames. J Virol 1998, 72(9):7294-7301.
92. Ciacci-Zanella J., Stone M., Henderson G., et al. The latency-related gene of bovine herpesvirus 1 inhibits programmed cell death. J Virol 1999, 73(12):9734-9740.
93. Henderson G., Perng G.C., Nesburn A., et al. The latency related gene of bovine herpesvirus 1 can suppress caspase 3 and caspase 9 during productive infection. J Neurovirol 2004, 10:64-70.
94. Bratanich A.C., Hanson N.D., Jones C. The latency-related gene of bovine herpesvirus 1 inhibits the activity of immediate-early transcription unit 1. Virology 1992, 191(2):988-991.
95. Geiser V., Inman M., Zhang Y., et al. The latency related (LR) gene of bovine herpes virus 1 (BHV-1) can inhibit the ability of bICP0 to activate productive infection. J Gen Virol 2002, 83:2965-2971.
96. Jones C., Newby T.J., Holt T., et al. Analysis of latency in cattle after inoculation with a temperature sensitive mutant of bovine herpesvirus 1 (RLB106). Vaccine 2000, 18(27):3185-3195.
97. Rock D., Lokensgard J., Lewis T., et al. Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1. J Virol 1992, 66(4):2484-2490.
98. Winkler M.T., Doster A., Jones C. Persistence and reactivation of bovine herpesvirus 1 in the tonsil of latently infected calves. J Virol 2000, 74:5337-5346.
99. Fuchs M., Hubert P., Detterer J., et al. Detection of bovine herpesvirus type 1 in blood from naturally infected cattle by using a sensitive PCR that discriminates between wild-type virus and virus lacking glycoprotein E. J Clin Microbiol 1999, 37(8):2498-2507.
100. Mweene A.S., Okazaki K., Kida H. Detection of viral genome in non-neural tissues of cattle experimentally infected with bovine herpesvirus 1. Jpn J Vet Res 1996, 44(3):165-174.
101. Cheung A.K. Investigation of pseudorabies virus DNA and RNA in trigeminal ganglia and tonsil tissues of latently infected swine. Am J Vet Res 1995, 56:45-50.
102. Sabo A., Rajanci J. Latent pseudorabies virus infection in pigs. Acta Virologica 1976, 20:208-214.
103. Borchers K., Wolfinger U., Ludwig H. Latency-associated transcript of equine herpesvirus 4 in trigeminal ganglia of naturally infected horses. J Gen Virol 1999, 80:2165-2171.
104. Miyoshi M., Ishii Y., Takiguchi M., et al. Detection of canine herpesvirus DNA in ganglionic neurons and the lymph node lymphocytes of latently infected dogs. J Vet Med Sci 1999, 61:375-379.
105. Perez S., Inman M., Doster A., et al. Latency-related gene encoded by bovine herpesvirus 1 promotes virus growth and reactivation from latency in tonsils of infected calves. J Clin Microbiol 2005, 43:393-401.
106. Kutish G., Mainprize T., Rock D. Characterization of the latency-related transcriptionally active region of the bovine herpesvirus 1 genome. J Virol 1990, 64(12):5730-5737.
107. Rock D.L., Beam S.L., Mayfield J.E. Mapping bovine herpesvirus type 1 latency-related RNA in trigeminal ganglia of latently infected rabbits. J Virol 1987, 61(12):3827-3831.
108. Jiang Y., Hossain A., Winkler M.T., et al. A protein encoded by the latency-related gene of bovine herpesvirus 1 is expressed in trigeminal ganglionic neurons of latently infected cattle and interacts with cyclin-dependent kinase 2 during productive infection. J Virol 1998, 72(10):8133-8142.
109. Jiang Y., Inman M., Zhang Y., et al. A mutation in the latency related gene of bovine herpesvirus 1 (BHV-1) inhibits protein expression of a protein from open reading frame 2 (ORF-2) and an adjacent reading frame during productive infection. J Virol 2004, 78:3184-3189.
110. Hossain A., Schang L.M., Jones C. Identification of gene products encoded by the latency-related gene of bovine herpesvirus 1. J Virol 1995, 69(9):5345-5352.
111. Schang L.M., Hossain A., Jones C. The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J Virol 1996, 70(6):3807-3814.
112. Shen W., Jones C. Open reading frame 2 encoded by the latency related gene of bovine herpesvirus 1 has anti-apoptosis activity in transiently transfected neuroblastoma cells. J Virol 2008, 82:10940-10945.
113. Geiser V., Jones C. The latency related gene encoded by bovine herpesvirus 1 encodes a small regulatory RNA that inhibits cell growth. J Neurovirol 2005, 11:563-570.
114. Inman M., Lovato L., Doster A., et al. A mutation in the latency-related gene of bovine herpesvirus 1 leads to impaired ocular shedding in acutely infected calves. J Virol 2001, 75:8507-8515.
115. Van Drunen Littel-van den Hurk S. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. Vet Microbiol 2005, 113:275-282.
116. +, and γδ T cells in calves vaccinated with one dose of a modified live BHV-1 vaccine. Viral Immunol 2002, 15:385-393.
117. Butchi N.B., Jones C., Perez S., et al. Envelope protein Us9 is required for the anterograde transport of bovine herpesvirus-1 (BHV-1) from trigeminal ganglia to nose and eye upon reactivation. J Neurovirol 2007, 13:384-388.
118. Chowdhury S.I., Ross C.S., Lee B.J., et al. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant. Am J Vet Res 1999, 60:227-232.
119. Chowdhury S.I. Construction and characterization of an attenuated bovine herpesvirus type 1 (BHV-1) recombinant virus. Vet Microbiol 1996, 52:13-23.
120. Kaashoek M.J., van Engelenburg F.A., Moerman A., et al. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants. Vet Microbiol 1996, 48:143-153.
121. Kaashoek M.J., Rijsewijk F.A., Oirschot J.T. Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection. Vet Microbiol 1996, 53(1-2):103-110.
122. Liu Z, Coats C, Jones C, Chowdhury SI. Construction and characterization of BHV-1 glycoprotein E (gE) cytoplasmic tail truncated and Us9 acidic domain deleted mutants. 32nd International Herpesvirus Workshop, Ashville, NC; 2007. 3.36.
123. Chowdhury S.I., Lee B.J., Ozkul A., et al. Bovine Herpesvirus type-5 (BHV-5) glycoprotein E (gE) is important for neuroinvasiveness and neurovirulence in the olfactory pathway of the rabbit. J Virol 2000, 74:2094-2106.
124. Whitbeck J.C., Knapp A.C., Enquist L.W., et al. Synthesis, processing, and oligomerization of the bovine herpes virus 1 gE and gI membrane proteins. J Virol 1996, 70:7878-7884.
125. Thriy E., Muylkens B., Meurens F., et al. Recombination in the alphaherpesvirus bovine herpesvirus 1. Vet Microbiol 2005, 113:171-177.
126. Ellis J., Waldner C., Rhodes C., et al. Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modified-live virus vaccine in beef calves. J Am Vet Med Assoc 2005, 227:123-128.
127. Van Drunen Littel-van den Hurk S., Myers D., Doig P.A., et al. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination. Can J Vet Res 2001, 65:81-88.
128. Ackermann M., Engels M. Pro and contra IBR-eradication. Vet Microbiol 2006, 113:293-302.
129. Katze M.G., Heng Y., Gale M. Viruses and interferon: fight for supremacy. Nat Rev Immunol 2002, 2:675-686.
130. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002, 3:651-662.
131. Aaronson D.S., Horvath C.M. A road map for those who don't know JAK-STAT. Science 2002, 296:1653-1655.
132. Alexopoulou L., Holt A.C., Medzhitov R., et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
133. Doyle S., Vaidya S., O'Connell R., et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002, 17:251-263.
134. Fitzgerald K.A., McWhirter S.M., Faja K.L., et al. IKKe and TBKI are essential components of the IRF3 signaling pathway. Nature 2003, 4:491-496.
135. Sharma S., tenOever B.R., Grandvaux N., et al. Triggering the interferon antiviral response through and IKK-related pathway. Science 2003, 300:1148-1151.
136. Wathelet M.G., Lin C.H., Parekh B.S., et al. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-b enhancer in vivo. Mol Cell 1998, 1:507-518.
137. Guo J., Peters K.L., Sen G.C. Induction of the human protein P56 by interferon, double stranded RNA, or virus infection. Virology 2000, 267:209-219.
138. Mossman K.L., Macgregor P.F., Rozmus J.J., et al. Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 2001, 75(2):750-758.
139. Perkins N.D. Integrating cell-signalling pathways with NF-kB and IKK functions. Nat Rev Mol Cell Biol 2007, 8:49-62.
140. Jaeschke A., Karasarides M., Ventura J.J., et al. JNK2 is a positive regulator of the cJun transcription factor. Mol Cell 2006, 23:899-911.
141. Weaver B.K., Kumar K.P., Reich N.C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol 1998, 18:1359-1368.